Genetic analysis of benign ovarian tumors
- 20 March 2003
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 105 (4) , 499-505
- https://doi.org/10.1002/ijc.11107
Abstract
Ovarian cancer represents a major cause of cancer death among women and yet remarkably little is known about its etiology. The paradigm established by the colorectal carcinogenesis model would suggest that ovarian cancers are likely to arise through malignant transformation of benign ovarian tumors. However, molecular genetic data that could answer this important question is lacking. In our study, we analyzed 80 benign ovarian tumors for TP53 and K‐ras mutations and for LOH on chromosomes 6, 7, 9, 11 and 17 using 56 microsatellite markers. Twenty‐five percent (5/20) of non‐epithelial tumors and 73% (44/60) of epithelial tumors exhibited LOH on at least 1 chromosome arm. A particularly high frequency of LOH was detected among the epithelial tumors on chromosome arms 6q (17%), 7p (17%), 7q (27%) and 11p (18%), which are also regions of frequent LOH among ovarian carcinomas. No K‐ras mutations were detected in any tumor but somatic TP53 mutations were detected in 2/34 (6%) serous and 1/26 (4%) mucinous epithelial tumors. In contrast to most previous studies our data is derived from a relatively large number of microdissected tumors and is likely to represent a more accurate picture of the frequency of alterations in these tumors. We conclude that LOH is common in benign ovarian tumors, suggesting that inactivation of tumor suppressor genes are pivotal in their development. The high frequency of alterations is consistent with their being precursors to malignant disease but does not unequivocally prove this continuum. It does however provide a framework for future analysis of the molecular genetic etiology of ovarian tumorigenesis.Keywords
This publication has 34 references indexed in Scilit:
- Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancersOncogene, 2000
- Absence of PPP2R1B gene alterations in primary ovarian cancersOncogene, 1999
- Frequent loss of heterozygosity on chromosomes 7 and 9 in benign epithelial ovarian tumoursOncogene, 1997
- Whole genome amplification of single cells from clinical peripheral blood smears.Molecular Pathology, 1997
- Analysis of loss of heterozygosity andKRAS2 mutations in ovarian neoplasms: Clinicopathological correlationsGenes, Chromosomes and Cancer, 1997
- The Relationship between Borderline Ovarian Tumors and Epithelial Ovarian Carcinoma: Epidemiologic, Pathologic, and Molecular AspectsGynecologic Oncology, 1996
- Alteration of the p53 Tumor Suppressor Gene Occurs Independently of K‐ras Activation and More Frequently in Serous Adenocarcinomas than in Other Common Epithelial Tumors of the Human OvaryJapanese Journal of Cancer Research, 1994
- Investigation of loss of heterozygosity at specific loci on chromosomes 3p, 6q, lip, 17p and 17q in ovarian cancerInternational Journal of Gynecologic Cancer, 1993
- Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancerInternational Journal of Cancer, 1992
- Detection of p53 Gene Mutations in Human Ovarian and Endometrial Cancers by Polymerase Chain Reaction‐Single Strand Conformation Polymorphism AnalysisJapanese Journal of Cancer Research, 1992